Therapy-Related Myeloid Neoplasm in Methotrexate-Associated Lymphoproliferative Disease in a Rheumatoid Arthritis Patient

Methotrexate (MTX) has been reported as one of the most potent drugs causing other iatrogenic immunodeficiency-associated lymphoproliferative diseases (OIIA-LPDs). Recently, we experienced a rare case of OIIA-LPDs in a rheumatoid arthritis (RA) patient; a 58-year-old female patient developed high fe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Clinical and Experimental Hematopathology 2014, Vol.54(2), pp.137-141
Hauptverfasser:	Tokuhira, Michihide, Kimura, Yuta, Nemoto, Tomoe, Sagawa, Morihiko, Tomikawa, Tatsuki, Sakai, Ryota, Okuyama, Ayumi, Amano, Koichi, Higashi, Morihiro, Tamaru, Jun-ichi, Mori, Shigehisa, Tabayashi, Takayuki, Watanabe, Reiko, Kizaki, Masahiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis, Rheumatoid - complications Bone Marrow - pathology Fatal Outcome Female Humans Immunohistochemistry Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use In Situ Hybridization, Fluorescence Leukemia, Myeloid - diagnosis Leukemia, Myeloid - etiology Lymphoproliferative Disorders - chemically induced Lymphoproliferative Disorders - diagnosis methotrexate Methotrexate - adverse effects Methotrexate - therapeutic use Middle Aged Neoplasms, Second Primary - diagnosis Neoplasms, Second Primary - etiology other iatrogenic immunodeficiency-associated lymphoproliferative diseases rheumatoid arthritis therapy-related acute myeloid leukemia/myelodysplastic syndrome therapy-related myeloid neoplasm
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!